GWSG
AZN icon

GPS Wealth Strategies Group’s AstraZeneca AZN Stock Holding History

GPS Wealth Strategies Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$136K Sell
741
-2,160
-74% -$379K 0.12% 121
2025
Q3 		$445K Hold
2,901
– – 0.05% 204
2025
Q2 		$405K Buy
2,901
+28
+1% +$3.92K 0.05% 207
2025
Q1 		$422K Buy
2,873
+24
+0.8% +$3.47K 0.06% 196
2024
Q4 		$373K Sell
2,849
-45
-2% -$6.3K 0.05% 209
2024
Q3 		$451K Buy
2,894
+35
+1% +$5.65K 0.06% 194
2024
Q2 		$446K Buy
2,859
+92
+3% +$13.8K 0.07% 172
2024
Q1 		$375K Sell
2,767
-164
-6% -$21.7K 0.06% 185
2023
Q4 		$395K Sell
2,931
-77
-3% -$10K 0.07% 175
2023
Q3 		$407K Sell
3,008
-15
-0.5% -$2.05K 0.08% 164
2023
Q2 		$433K Hold
3,023
– – 0.08% 159
2023
Q1 		$420K Buy
+3,023
New +$407K 0.09% 157
2022
Q4 		– Sell
-2,893
Closed -$317K – 185
2022
Q3 		$317K Hold
2,893
– – 0.08% 158
2022
Q2 		$382K Buy
2,893
+28
+1% +$3.67K 0.1% 149
2022
Q1 		$380K Hold
2,865
– – 0.09% 139
2021
Q4 		$334K Buy
2,865
+10
+0.4% +$1.18K 0.07% 157
2021
Q3 		$343K Buy
2,855
+455
+19% +$53K 0.08% 145
2021
Q2 		$287K Sell
2,400
-75
-3% -$8.23K 0.07% 163
2021
Q1 		$246K Buy
2,475
+276
+13% +$27.7K 0.07% 166
2020
Q4 		$220K Buy
2,199
+334
+18% +$35.4K 0.08% 161
2020
Q3 		$204K Buy
+1,865
New +$207K 0.08% 144

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

GPS Wealth Strategies Group's AZN Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its AstraZeneca (AZN) stake by 74% in Q4 2025, selling an estimated $379K and leaving 741 shares worth $136K. The position accounts for 0.12% of the portfolio, ranked #121.

GPS Wealth Strategies Group first reported a position in AZN in Q3 2020 and has held it in 21 quarters since. The position peaked at $451K in Q3 2024. 1,407 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • GPS Wealth Strategies Group held 741 shares of AstraZeneca worth $136K as of Q4 2025.
  • GPS Wealth Strategies Group sold 2,160 AstraZeneca shares in Q4 2025, an estimated $379K.
  • AstraZeneca made up 0.12% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #121 holding.
  • GPS Wealth Strategies Group first reported a position in AstraZeneca in Q3 2020 and has held it in 21 quarters since.
  • GPS Wealth Strategies Group's AstraZeneca position peaked at $451K in Q3 2024.
  • 1,407 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.